News Archives - Page 8 of 87

ThursdayMay 30, 2024 2:10 pm

TinyGemsBreaks – AZZ Inc. (NYSE: AZZ) Closes on Common Stock Public Offering, Including Underwriters’ Option

AZZ (NYSE: AZZ), the leading independent provider of hot-dip galvanizing and coil-coating solutions, has closed on its underwritten public offering. The offering consists of 4,600,000 shares of common stock along with the full exercise of the underwriters' option, which included the purchase of up to 600,000 additional shares of common stock. The shares were offered at a price per share of $70 resulting in gross proceeds of $322 million for the company, before standard deductions, commissions and fees were paid. AZZ anticipates using the funds from the offering for the redemption of all or a portion of the company's 6.0% Series A Convertible…

ThursdayMay 30, 2024 1:57 pm

TinyGemsBreaks – Asset Marketing Systems Partners to Provide Straightforward Method for Investors to Obtain Medallion Signature Guarantees

Asset Marketing Systems Insurance Services, LLC (“Asset”) is a premier distributor of insurance products specializing in Fixed Index Annuities, Fixed Annuities, Life, and Asset-Based Insurance. Asset today announced a strategic partnership with eSignature Group LLC, a leading provider of online medallion signature guarantees. eSignature is an online ID verification service that enables investors to receive a medallion without having to find a physical branch location and is available to all verified shareholders within the U.S. According to the announcement, this collaboration presents a significant advancement from a compliance, convenience, and technology perspectives. It allows U.S. investors to receive a medallion…

ThursdayMay 30, 2024 11:31 am

TinyGemsBreaks – ECGI Holdings Inc. (ECGI) Announces Agreement to Convert $2M Debt to Equity

ECGI Holdings (OTC: ECGI), a diversified holding company, is announcing a debt-to-equity conversion. According to the announcement, the creators of the 3(a)(10) have agreed to convert $2 million of debt into equity. This conversion marks a significant milestone in the company’s ongoing efforts to enhance financial stability and maximize shareholder value and represents a pivotal step in its financial optimization strategy. The announcement noted that the move to convert $2 million of debt into equity enables the company to not only reduce its liabilities but also strengthen its balance sheet. “This conversion will alleviate a significant portion of our financial…

WednesdayMay 29, 2024 1:44 pm

TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO to Participate at Upcoming BIO International Convention 2024

Predictive Oncology (NASDAQ: POAI), a leader in artificial-intelligence (“AI”)-driven drug discovery and biologics, will be spotlighted at next month’s BIO International Convention 2024. The conference is scheduled for June 3–6, 2024, in San Diego. According to the announcement, Predictive Oncology CEO Raymond Vennare will be presenting a company overview at the gathering. His presentation, titled “Novel AI Driven Insights to Guide Early Drug Discovery,” is slated to begin at 6:45 EDT on June 3, 2023. “We are very pleased to participate in this year’s Bio International Convention, which is the premier gathering of biopharmaceutical stakeholders from around the world,” said…

ThursdayMay 23, 2024 12:06 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is partnering with a contract research organization (“CRO”) to conduct its human pilot study #3. According to the announcement, this is the first-ever DehydraTECH(TM)-processed tirzepatide from Zepbound(R) to be tested in a swallowed oral format. The study is designed to evaluate a dual-action GLP-1 (glucagon-like peptide) plus GIP (glucose-dependent insulintropic peptide) in a randomized, crossover investigation that will compare injected Zepbound tirzepatide by Eli Lilly to a compound formulated, DehydraTECH-processed tirzepatide that is derived from Zepbound but in a capsule form. Test articles for the study will be manufactured…

WednesdayMay 22, 2024 12:02 pm

TinyGemsBreaks – SenesTech Inc. (NASDAQ: SNES) Takes ‘Significant Step’ in Distribution of Flagship Product with Opening of Online Store on Amazon

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, has launched a dedicated online store on Amazon for Evolve(TM), its minimum-risk, soft bait for the proactive control of rats. Calling the move a “significant step forward in the distribution of Evolve,” the company noted that Evolve addresses the fundamental issue of rodent overpopulation by focusing on their rapid reproduction rates. Numerous independent studies indicate that the active ingredient in Evolve effectively reduces fertility in rodents. Research shows that two rats with sufficient food, water and shelter can produce up to 15,000 offspring within the year, and Evolve…

WednesdayMay 22, 2024 10:56 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN), Bollinger Partner with EnviroCharge to Create Innovative Mobile Charging Solution

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, and Bollinger Motors, a majority-owned company of Mullen, is partnering with EnviroCharge, a provider of convenient and flexible charging solutions, to create an innovative mobile charging solution for electric vehicle fleet owners; the solution enables EV owners to charge their vehicles quickly and easily anytime, anywhere. According to the announcement, Mullen and Bollinger have sold 50 vehicles to EnviroCharge, which will install its mobile, clean-propane-powered charging system on the Bollinger B4 chassis cab, an all-electric Class 4 commercial truck. The agreement between the companies has an estimated deal value of $8,250,000 for…

MondayMay 20, 2024 1:21 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at 2024 Healthcare Company Showcase

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that its Chief Executive Officer John Climaco will participate in a fireside chat at the Healthcare Company Showcase hosted by Alliance Global Partners. Climaco’s presentation is slated to begin at 1:40 p.m. ET on May 21, 2024. A live webcast will be available on the Events page of CNSP’s website. To view the full press release, visit https://ibn.fm/OSiDy About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company…

MondayMay 20, 2024 11:52 am

TinyGemsBreaks – NextPlat Corp’s (NASDAQ: NXPL) GTC Begins Sales of SpaceX’s Starlink as Authorized Reseller

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that its subsidiary, Global Telesat Communications Ltd (“GTC”), through a new joint venture agreement with Pivotel Solutions Inc. (dba “Pulsar”) is now a global authorized reseller of SpaceX’s Starlink satellite-based connectivity products. Under the agreement as as an approved reseller, GTC will immediately begin offering Starlink connectivity services in the U.K. and other international markets serving mobile and maritime-based customers. Pulsar will provide GTC back-end systems support services on behalf of its new Starlink customers. “We are pleased to collaborate with Pulsar to begin offering SpaceX’s revolutionary Starlink, LEO-satellite based…

ThursdayMay 16, 2024 2:31 pm

TinyGemsBreaks – Armlogi Holding Corp. (NASDAQ: BTOC) Announces Public Offering Pricing

Armlogi Holding (NASDAQ: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, has released the pricing of its initial public offering. The offering is comprised of 1,600,000 shares of common stock at $5 per share, resulting in gross proceeds of $8 million for the company, before the deduction of underwriting discounts and offering expenses. According to the announcement, Armlogi Holding also granted a 45-day option to underwriters to purchase up to 240,000 additional shares of common stock to cover any overallotments. EF Hutton LLC is acting…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News